The Institutes for Pharmaceutical Discovery, LLC Company Profile

22:51 EDT 20th March 2018 | BioPortfolio

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced pharmaceutical executives, financial managers and dedicated senior scientists, all of whom have had extensive experience in pharmaceutical drug development. This group also oversees the vision and function of each individual institute it creates...


23 Business Park Drive
United States of America



News Articles [1119 Associated News Articles listed on BioPortfolio]

New study explains how your brain helps you learn new skills

(Gladstone Institutes) Researchers from the Gladstone Institutes uncovered how a special type of neuron improves the efficiency of procedural learning. They initially wanted to show how the specialize...

Beacon enters drug discovery collaboration with Janssen

US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to...Read More... The post Beacon enters drug d...

Research findings offer path for drug discovery to treat hyperaldosteronism

A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute, in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Developme...

MDI Biological Laboratory scientist receives grant to study aging

(Mount Desert Island Biological Laboratory) The MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging (N...

Otsuka and X-Chem to advance discovery process for drug compounds

Otsuka Pharmaceutical and biotechnology company X-Chem have signed an agreement to advance the discovery process for new Otsuka drug compounds....Read More... The post Otsuka and X-Chem to advance dis...

Astellas acquires drug discovery subsidiary Mitobridge

Japanese firm Astellas Pharma has exercised its exclusive option right to acquire US-based biotechnology company Mitobridge to accelerate the discovery...Read More... The post Astellas acquires drug d...

Beacon, the guiding light in antibody discovery? Another top 10 pharma signs up

Novartis will install Berkeley Lightsâ Beacon antibody discovery technology, the sixth large pharmaceutical firm to adopt the platform in less than a year.

Drug Discovery Outsourcing Global Market Forecast To 2025 [Report Updated: 14092017] Prices from USD $7200

Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biolog...

PubMed Articles [1061 Associated PubMed Articles listed on BioPortfolio]

Discovery and development of new antibacterial drugs: learning from experience?

Antibiotic (antibacterial) resistance is a serious global problem and the need for new treatments is urgent. The current antibiotic discovery model is not delivering new agents at a rate that is suffi...

Drug discovery, development and delivery in Alzheimer's disease.

The future of LC-MS for pharmaceutical analysis: an interview with Jun Qu.

Jun Qu speaks to Sankeetha Nadarajah, Editor of Bioanalysis: Jun Qu is the group leader of the proteomics and pharmaceutical analysis lab of SUNY-Buffalo (NY, USA) and a Professor in the Department of...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Using network-based expert engagement to advance pharmaceutical research and development.

Clinical Trials [591 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [2580 Associated Companies listed on BioPortfolio]

The Institutes for Pharmaceutical Discovery, LLC

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced ph...

Institute for Diabetes Discovery

The Institute for Diabetes Discovery, LLC, (IDD) is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics fo...

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis...

Tularik Incorporated

We have developed a drug discovery and development infrastructure that we believe positions us to become a leading pharmaceutical company. Our drug discovery and development expertise includes molecul...


Affymax, Inc. is a drug discovery powerhouse uniquely positioned to leverage over a decade of pharmaceutical drug discovery experience. As an industry pioneer with a five-year history working inside G...

More Information about "The Institutes for Pharmaceutical Discovery, LLC" on BioPortfolio

We have published hundreds of The Institutes for Pharmaceutical Discovery, LLC news stories on BioPortfolio along with dozens of The Institutes for Pharmaceutical Discovery, LLC Clinical Trials and PubMed Articles about The Institutes for Pharmaceutical Discovery, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institutes for Pharmaceutical Discovery, LLC Companies in our database. You can also find out about relevant The Institutes for Pharmaceutical Discovery, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record